gp41 fusion peptidegp41 fusion peptide fusion peptide - peptides-online-store gp41 fusion peptide Understanding the Role of the gp41 Fusion Peptide in HIV-1 Entry and Inhibition

peptide-university The gp41 fusion peptide (FP) is a critical component of the HIV-1 envelope glycoprotein complex, playing an indispensable role in the virus's ability to infect target cells. This peptide sequence, located at the N-terminus of gp41, is responsible for initiating the process of membrane fusion, a vital step for viral entry. Understanding the structure, function, and interactions of the gp41 fusion peptide is crucial for developing effective antiviral strategies.

Gp41 itself, also known as glycoprotein 41, is a subunit of the envelope protein complex of retroviruses, including human immunodeficiency virus (HIV). It works in conjunction with the gp120 subunit to mediate the attachment and entry of the virus into host cells. Following the binding of gp120 to the CD4 receptor and a co-receptor on the target cell, a conformational change occurs, exposing the gp41 fusion peptide.

The Mechanism of Membrane Fusion Initiated by the gp41 Fusion Peptide

The gp41 fusion peptide is believed to insert itself into the lipid bilayer of the host cell membrane. This insertion destabilizes the membrane and triggers a cascade of conformational changes within gp41. Current models suggest that gp41 catalyses membrane fusion by undergoing a refolding process that brings the viral and cellular membranes into close proximityCrystal Structure of HIV-1 gp41 Including Both Fusion Peptide .... This process ultimately leads to the formation of a fusion pore, allowing the viral genetic material to enter the cell.作者：DH Jang·被引用次数：6—Characterization of Gp41 Polymorphisms in the Fusion Peptide Domainand T-20 (Enfuvirtide) Resistance-Associated Regions in Korean HIV-1 Isolates.

Research into the structure of HIV-1 gp41 has revealed its complexity, with the gp41 protein possessing functionally critical domains.作者：V Buzon·2010·被引用次数：377—Gp41 catalyses membrane fusionand current models suggest that receptor binding leads to the exposure of the gp41 fusion peptide (FP), which ... The fusion peptide region is a key element in this structure, and its interaction with membranes has been extensively studied.作者：V Buzon·2010·被引用次数：377—Gp41 catalyses membrane fusionand current models suggest that receptor binding leads to the exposure of the gp41 fusion peptide (FP), which ... Studies have shown that the HIV gp41 fusion peptide can adopt different structures, such as an α-helical or β-sheeted structure, depending on the surrounding environment, including its interaction with liposomesAlterations in gp120 glycans or the gp41 fusion peptide .... This conformational flexibility is likely important for its function in membrane fusion.

Targeting the gp41 Fusion Peptide for Antiviral Therapies

The central role of the gp41 fusion peptide in viral entry makes it an attractive target for antiviral drugs.作者：M Cano-Muñoz·2022·被引用次数：9—Inhibition of the HIV-1fusionprocess constitutes a promising strategy to neutralize the virus at an early stage before it enters the cell. Inhibitors that block the function of the gp41 fusion peptide can effectively prevent HIV-1 from infecting cells. Several classes of peptides have been developed that target different stages of the gp41-mediated fusion process.

One notable example is Enfuvirtide (T20), a peptide fusion inhibitor that mimics a portion of the gp41 heptad repeat (HR) regions.Anti-gp41 Antibodies Cloned from HIV-Infected Patients with Broadly ... T20 binds to the N-terminal heptad repeat (HR1) of gp41, preventing the formation of the coiled-coil structure necessary for membrane fusion. Other peptides, such as C34 and C-peptides derived from the gp41 C-terminal heptad repeat (CHR), also act as potent HIV fusion inhibitors by interfering with the refolding of gp411erf - CONFORMATIONAL MAPPING OF THE N .... These peptides can specifically inhibit viral entry at low nanomolar concentrations by interacting with the gp41 fusion intermediate.

Furthermore, researchers are exploring the development of anti-gp41 antibodies cloned from HIV-infected patients that exhibit broadly neutralizing activity. These antibodies can target different epitopes on gp41, including those related to the fusion peptideCharacterization of Gp41 Polymorphisms in the Fusion ....

Investigating gp41 Fusion Peptide Polymorphisms and Variations

Understanding variations within the gp41 fusion peptide sequence is also important for several reasons. Characterization of Gp41 Polymorphisms in the Fusion Peptide Domain can provide insights into viral evolution and the development of resistance to antiviral drugs作者：Q Qi·2017·被引用次数：21—These threepeptidessignificantly enhanced protein-mediated inactivation against cell-free HIV-1 virions, including HIV-1 laboratory-adapted and primary HIV-1 .... Studies have investigated gp41 polymorphisms in the fusion peptide domain and associated regions, such as those related to T-20 (Enfuvirtide) resistanceA number ofpeptidesderived from thegp41CHR (C-peptides) can specifically inhibit viral entry at low nanomolar concentration, such as C34, T20 [5–9]. It is .... These investigations help in understanding how mutations in the gp41 fusion peptide might affect its function or lead to reduced sensitivity to inhibitors.

The study of conformational mapping of the n-terminal fusion peptide of hiv-1 gp41 using techniques like 13C-enhanced Fourier transform infrared spectroscopy (FTIR) provides detailed structural information about this critical region.作者：DH Jang·被引用次数：6—Characterization of Gp41 Polymorphisms in the Fusion Peptide Domainand T-20 (Enfuvirtide) Resistance-Associated Regions in Korean HIV-1 Isolates. This knowledge is instrumental in designing more potent and specific inhibitors期刊篇目查詢-詳情.

In summary, the gp41 fusion peptide is a fundamental element in the HIV-1 life cycle, driving virus-cell fusion. Its unique properties and crucial role in viral entry have made it a prime target for therapeutic interventions. Continued research into the structure, function, and variations of the gp41 fusion peptide is vital for advancing our ability to combat HIV infection.